CVRx Inc

CVRXNASDAQ · USD
0.61USD0.00 (-0.33%)
642

CVRx Inc (CVRX) Covered Calls

Read more

Running CVRX covered calls helps you generate income from CVRx Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best CVRX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If CVRX stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling CVRX covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given CVRX covered call is worth writing.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

No illustrative rows to display.

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank98.81% High
  • Market cap (M$)17
  • 52 weeks high-94.07%
  • 52 weeks low1.67%
  • Analyst recommendationHold
    3.00
  • Target price$1.65
    268.25% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2027-02-11
  • P/E—
  • Future P/E—
  • EPS (ttm)-2.00
  • EPS growth next 5 years9.00%

As of Nov 16, 2026